Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 60 articles:
HTML format
Text format



Single Articles


    June 2018
  1. KANDA M, Tanaka H, Shimizu D, Miwa T, et al
    SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.
    Oncogene. 2018 Jun 1. pii: 10.1038/s41388-018-0335.
    PubMed     Text format     Abstract available


    May 2018
  2. LIU H, Chen W, Zhi X, Chen EJ, et al
    Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility.
    Oncogene. 2018 May 22. pii: 10.1038/s41388-018-0309.
    PubMed     Text format     Abstract available


  3. TAN S, Li H, Zhang W, Shao Y, et al
    NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Oncogene. 2018 May 21. pii: 10.1038/s41388-018-0280.
    PubMed     Text format     Abstract available


  4. PINATO DJ
    Circulating-free tumour DNA and the promise of disease phenotyping in hepatocellular carcinoma.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0262.
    PubMed     Text format    


    April 2018
  5. LABGAA I, Villacorta-Martin C, D'Avola D, Craig AJ, et al
    A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma.
    Oncogene. 2018 Apr 9. pii: 10.1038/s41388-018-0206.
    PubMed     Text format     Abstract available


    March 2018
  6. SU T, Liao J, Dai Z, Xu L, et al
    Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0169.
    PubMed     Text format     Abstract available


  7. EHEDEGO H, Mohs A, Jansen B, Hiththetiya K, et al
    Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.
    Oncogene. 2018 Mar 19. pii: 10.1038/s41388-018-0181.
    PubMed     Text format     Abstract available


  8. WANG J, Dong M, Xu Z, Song X, et al
    Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
    Oncogene. 2018 Mar 16. pii: 10.1038/s41388-018-0188.
    PubMed     Text format     Abstract available


  9. DONG L, Yu L, Bai C, Liu L, et al
    USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis.
    Oncogene. 2018 Mar 2. pii: 10.1038/s41388-018-0137.
    PubMed     Text format     Abstract available


    January 2018
  10. HUA S, Lei L, Deng L, Weng X, et al
    miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Oncogene. 2018 Jan 16. pii: 10.1038/s41388-017-0057.
    PubMed     Text format     Abstract available


  11. LIU MX, Jin L, Sun SJ, Liu P, et al
    Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.
    Oncogene. 2018 Jan 16. pii: 10.1038/s41388-017-0070.
    PubMed     Text format     Abstract available


    December 2017
  12. GUO P, Wang Y, Dai C, Tao C, et al
    Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/beta-catenin-induced FGF18 expression in hepatocellular carcinoma.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0017.
    PubMed     Text format     Abstract available


    November 2017
  13. DING D, Huang H, Jiang W, Yu W, et al
    Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
    Oncogene. 2017;36:6747-6748.
    PubMed     Text format     Abstract available


  14. NAKATSUKA T, Tateishi K, Kudo Y, Yamamoto K, et al
    Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Oncogene. 2017;36:6262-6271.
    PubMed     Text format     Abstract available


    October 2017
  15. DEBEBE A, Medina V, Chen CY, Mahajan IM, et al
    Wnt/beta-catenin activation and macrophage induction during liver cancer development following steatosis.
    Oncogene. 2017;36:6020-6029.
    PubMed     Text format     Abstract available


  16. REN T, Zhang H, Wang J, Zhu J, et al
    MCU-dependent mitochondrial Ca2+ inhibits NAD+/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells.
    Oncogene. 2017;36:5897-5909.
    PubMed     Text format     Abstract available


  17. NAKAYAMA M, Sakai E, Echizen K, Yamada Y, et al
    Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Oncogene. 2017;36:5885-5896.
    PubMed     Text format     Abstract available


  18. GUO P, Ma X, Zhao W, Huai W, et al
    TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Oncogene. 2017 Oct 2. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    September 2017
  19. XIE X, Guo P, Yu H, Wang Y, et al
    Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  20. TRAN DDH, Kessler C, Niehus SE, Mahnkopf M, et al
    Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs.
    Oncogene. 2017 Sep 4. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    August 2017
  21. FENG GX, Li J, Yang Z, Zhang SQ, et al
    Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.
    Oncogene. 2017 Aug 28. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  22. LI J, Huang Q, Long X, Guo X, et al
    Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.
    Oncogene. 2017;36:4901-4912.
    PubMed     Text format     Abstract available


  23. HAN H, Yang B, Wang W
    Angiomotin-like 2 interacts with and negatively regulates AKT.
    Oncogene. 2017;36:4662-4669.
    PubMed     Text format     Abstract available


  24. LI J, Hu SB, Wang LY, Zhang X, et al
    Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  25. GOVAERE O, Petz M, Wouters J, Vandewynckel YP, et al
    The PDGFRalpha-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  26. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer.
    Oncogene. 2017;36:4405-4414.
    PubMed     Text format     Abstract available


    July 2017
  27. DING D, Huang H, Jiang W, Yu W, et al
    Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
    Oncogene. 2017 Jul 24. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  28. FAN LC, Shiau CW, Tai WT, Hung MH, et al
    SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    June 2017
  29. XIONG H, Ni Z, He J, Jiang S, et al
    LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
    Oncogene. 2017;36:3528-3540.
    PubMed     Text format     Abstract available


    May 2017
  30. CROSAS-MOLIST E, Bertran E, Rodriguez-Hernandez I, Herraiz C, et al
    The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination.
    Oncogene. 2017;36:3002-3014.
    PubMed     Text format     Abstract available


  31. CHI HC, Chen SL, Lin SL, Tsai CY, et al
    Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  32. XIN B, Yamamoto M, Fujii K, Ooshio T, et al
    Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    March 2017
  33. CHEN H, Cai W, Chu ES, Tang J, et al
    Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  34. HU X, Zhao Y, Wei L, Zhu B, et al
    CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  35. ZHOU M, Mok MT, Sun H, Chan AW, et al
    The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  36. DENG L, Tang J, Yang H, Cheng C, et al
    MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  37. ZHANG HR, Wang XD, Yang X, Chen D, et al
    An FGFR inhibitor converts the tumor promoting effect of TGF-beta by the induction of fibroblast-associated genes of hepatoma cells.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    February 2017
  38. BATTISTELLI C, Cicchini C, Santangelo L, Tramontano A, et al
    The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition.
    Oncogene. 2017;36:942-955.
    PubMed     Text format     Abstract available


  39. SUN H, Peng Z, Tang H, Xie D, et al
    Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-beta signaling in and promote progression of hepatocellular carcinoma.
    Oncogene. 2017 Feb 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  40. LIN Y, Yang X, Liu W, Li B, et al
    Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  41. HERMANNS C, Hampl V, Holzer K, Aigner A, et al
    The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  42. MENG Z, Ma X, Du J, Wang X, et al
    CAMK2gamma antagonizes mTORC1 activation during hepatocarcinogenesis.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  43. FAN H, Cui Z, Zhang H, Mani SK, et al
    DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
    Oncogene. 2016 Oct 31. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  44. LIAO PH, Hsu HH, Chen TS, Chen MC, et al
    Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury.
    Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  45. HAASE G, Gavert N, Brabletz T, Ben-Ze'ev A, et al
    A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  46. DENG Y, Cheng J, Fu B, Liu W, et al
    Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    August 2016
  47. CAO C, Zhang T, Zhang D, Xie L, et al
    The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.
    Oncogene. 2016 Aug 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  48. ZHOU X, Zhang CZ, Lu SX, Chen GG, et al
    miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.
    Oncogene. 2016 Aug 8. doi: 10.1038/onc.2016.
    PubMed     Text format    


  49. LIN KT, Shann YJ, Chau GY, Hsu CN, et al
    Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.
    Oncogene. 2016 Aug 1. doi: 10.1038/onc.2016.
    PubMed     Text format    


    May 2016
  50. SHEN J, Tsoi H, Liang Q, Chu ES, et al
    Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
    Oncogene. 2016 May 2. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  51. LIU F, Yuan JH, Huang JF, Yang F, et al
    Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  52. WU J, Lu M, Li Y, Shang YK, et al
    Regulation of a TGF-beta1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  53. NA TY, Ka NL, Rhee H, Kyeong D, et al
    Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    March 2016
  54. MORIOKA S, Sai K, Omori E, Ikeda Y, et al
    TAK1 regulates hepatic lipid homeostasis through SREBP.
    Oncogene. 2016 Mar 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    February 2016
  55. HUNG MH, Chen YL, Chu PY, Shih CT, et al
    Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential.
    Oncogene. 2016 Feb 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  56. AHRONIAN LG, Zhu LJ, Chen YW, Chu HC, et al
    A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination.
    Oncogene. 2016 Feb 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2016
  57. WANG W, Liao P, Shen M, Chen T, et al
    SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62.
    Oncogene. 2016;35:491-500.
    PubMed     Text format     Abstract available


  58. URTASUN R, Elizalde M, Azkona M, Latasa MU, et al
    Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression.
    Oncogene. 2016 Jan 25. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    July 2015
  59. ZHU G, Li X, Guo B, Ke Q, et al
    PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
    Oncogene. 2015 Jul 27. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    March 2015
  60. PARISI T, Bronson RT, Lees JA
    Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer.
    Oncogene. 2015 Mar 9. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: